A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

Clinical trial NCT00354445 · UNKNOWN

Trial details

NCT number: NCT00354445
Sponsor: Eyetech Pharmaceuticals
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Age-Related Macular Degeneration (AMD)

Start date: 2006-06-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.